Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

David Groheux,Mohamed Majdoub,Florent Tixier,Catherine Cheze Le Rest,Antoine Martineau,Pascal Merlet,Marc Espié,Anne de Roquancourt,Elif Hindié,Mathieu Hatt,Dimitris Visvikis

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

2015

David Groheux
Mohamed Majdoub
Florent Tixier
Catherine Cheze Le Rest
Antoine Martineau
Pascal Merlet
Marc Espié
Anne de Roquancourt
Elif Hindié
Mathieu Hatt
Dimitris Visvikis

Purpose The aim of this retrospective study was to determine if some features of baseline 18F-FDG PET images, including volume and heterogeneity, reflect clinical, histological or immunohistochemical characteristics in patients with stage II or III breast cancer (BC).

Keywords:

Radiology
Breast cancer
Medicine
Pathology
PET-CT
Retrospective cohort study
Immunohistochemistry
stage ii
fdg pet ct
in patient
tomography x ray computed
Positron emission tomography

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations